vs
Side-by-side financial comparison of AerSale Corp (ASLE) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
AerSale Corp is the larger business by last-quarter revenue ($90.9M vs $57.3M, roughly 1.6× RHYTHM PHARMACEUTICALS, INC.). AerSale Corp runs the higher net margin — 5.9% vs -83.0%, a 88.9% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -4.0%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 0.2%).
AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
ASLE vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.9M | $57.3M |
| Net Profit | $5.4M | $-47.5M |
| Gross Margin | 34.1% | 91.6% |
| Operating Margin | 7.8% | -82.2% |
| Net Margin | 5.9% | -83.0% |
| Revenue YoY | -4.0% | 36.9% |
| Net Profit YoY | 99.7% | -9.6% |
| EPS (diluted) | $0.10 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.9M | $57.3M | ||
| Q3 25 | $71.2M | $51.3M | ||
| Q2 25 | $107.4M | $48.5M | ||
| Q1 25 | $65.8M | $32.7M | ||
| Q4 24 | $94.7M | $41.8M | ||
| Q3 24 | $82.7M | $33.3M | ||
| Q2 24 | $77.1M | $29.1M | ||
| Q1 24 | $90.5M | $26.0M |
| Q4 25 | $5.4M | $-47.5M | ||
| Q3 25 | $-120.0K | $-52.9M | ||
| Q2 25 | $8.6M | $-46.6M | ||
| Q1 25 | $-5.3M | $-49.5M | ||
| Q4 24 | $2.7M | $-43.3M | ||
| Q3 24 | $509.0K | $-43.6M | ||
| Q2 24 | $-3.6M | $-32.3M | ||
| Q1 24 | $6.3M | $-141.4M |
| Q4 25 | 34.1% | 91.6% | ||
| Q3 25 | 30.2% | 89.3% | ||
| Q2 25 | 32.9% | 88.6% | ||
| Q1 25 | 27.3% | 88.8% | ||
| Q4 24 | 31.4% | 90.9% | ||
| Q3 24 | 28.6% | 88.5% | ||
| Q2 24 | 28.2% | 89.9% | ||
| Q1 24 | 31.8% | 89.2% |
| Q4 25 | 7.8% | -82.2% | ||
| Q3 25 | 4.0% | -102.6% | ||
| Q2 25 | 11.7% | -93.4% | ||
| Q1 25 | -10.1% | -143.7% | ||
| Q4 24 | 5.2% | -98.6% | ||
| Q3 24 | 2.4% | -132.0% | ||
| Q2 24 | -2.4% | -139.2% | ||
| Q1 24 | 5.2% | -538.7% |
| Q4 25 | 5.9% | -83.0% | ||
| Q3 25 | -0.2% | -103.1% | ||
| Q2 25 | 8.0% | -96.1% | ||
| Q1 25 | -8.0% | -151.4% | ||
| Q4 24 | 2.9% | -103.6% | ||
| Q3 24 | 0.6% | -131.2% | ||
| Q2 24 | -4.7% | -110.9% | ||
| Q1 24 | 6.9% | -544.4% |
| Q4 25 | $0.10 | $-0.73 | ||
| Q3 25 | $0.00 | $-0.82 | ||
| Q2 25 | $0.18 | $-0.75 | ||
| Q1 25 | $-0.10 | $-0.81 | ||
| Q4 24 | $0.05 | $-0.71 | ||
| Q3 24 | $0.01 | $-0.73 | ||
| Q2 24 | $-0.07 | $-0.55 | ||
| Q1 24 | $0.12 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $388.9M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $424.4M | $139.1M |
| Total Assets | $640.5M | $480.2M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $388.9M | ||
| Q3 25 | $5.3M | $416.1M | ||
| Q2 25 | $5.7M | $291.0M | ||
| Q1 25 | $4.7M | $314.5M | ||
| Q4 24 | $4.7M | $320.6M | ||
| Q3 24 | $9.8M | $298.4M | ||
| Q2 24 | $4.3M | $319.1M | ||
| Q1 24 | $2.6M | $201.2M |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | $424.4M | $139.1M | ||
| Q3 25 | $417.1M | $148.8M | ||
| Q2 25 | $415.9M | $-11.9M | ||
| Q1 25 | $406.5M | $18.9M | ||
| Q4 24 | $455.6M | $21.7M | ||
| Q3 24 | $451.5M | $11.2M | ||
| Q2 24 | $449.8M | $39.3M | ||
| Q1 24 | $452.0M | $61.6M |
| Q4 25 | $640.5M | $480.2M | ||
| Q3 25 | $646.3M | $506.9M | ||
| Q2 25 | $646.7M | $372.7M | ||
| Q1 25 | $646.1M | $386.7M | ||
| Q4 24 | $604.7M | $392.3M | ||
| Q3 24 | $601.5M | $363.6M | ||
| Q2 24 | $598.7M | $381.8M | ||
| Q1 24 | $571.7M | $258.7M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $-25.4M |
| Free Cash FlowOCF − Capex | $9.8M | — |
| FCF MarginFCF / Revenue | 10.8% | — |
| Capex IntensityCapex / Revenue | 1.7% | — |
| Cash ConversionOCF / Net Profit | 2.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $-25.4M | ||
| Q3 25 | $-8.9M | $-26.6M | ||
| Q2 25 | $19.8M | $-23.3M | ||
| Q1 25 | $-45.2M | $-40.4M | ||
| Q4 24 | $37.5M | $-18.8M | ||
| Q3 24 | $10.4M | $-25.2M | ||
| Q2 24 | $-15.3M | $-29.1M | ||
| Q1 24 | $-21.5M | $-40.7M |
| Q4 25 | $9.8M | — | ||
| Q3 25 | $-9.8M | — | ||
| Q2 25 | $18.6M | — | ||
| Q1 25 | $-47.6M | — | ||
| Q4 24 | $32.3M | — | ||
| Q3 24 | $8.9M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-25.0M | — |
| Q4 25 | 10.8% | — | ||
| Q3 25 | -13.8% | — | ||
| Q2 25 | 17.3% | — | ||
| Q1 25 | -72.4% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | -24.6% | — | ||
| Q1 24 | -27.7% | — |
| Q4 25 | 1.7% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | 3.9% | — |
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
RYTM
Segment breakdown not available.
